Has Chad Kliger, MD received payments from drug or device companies?

Yes. Drug and device makers reported $78,742 in general payments to Chad Kliger, MD across 187 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chad Kliger, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chad Kliger, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chad Kliger, MD

Internal Medicine · New York, NYNPI 1003824954

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 48.2% of the total. Reporting peaked in 2019 at $35,919 and has fallen 99.0% since, to $368 in 2025. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$78,742in general payments, 2019–2025

Across 187 payments — averaging $421.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Siemens Medical Solutions USA, Inc.$38K
Medtronic$20K
Edwards Lifesciences$14K
Abbott$3K
Boston Scientific$2K
Inari Medical, Inc.$792
plus $1K from 6 others

$1,444,810in research payments, 2019–2025

Across 160 payments — averaging $9030.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$728K
Siemens Medical Solutions USA, Inc.$522K
Bard Peripheral Vascular, Inc.$89K
Abbott$82K
Medtronic$24K

What the payments were for

Consulting fees$20,47526%
Speaking & faculty fees$35,21345%
Grants$1,8332%
Travel & lodging$10,91814%
Food & beverage$10,30313%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Siemens Medical Solutions USA, Inc.	26	$37,925
Medtronic(2 entities)	48	$20,169
Edwards Lifesciences	57	$13,608
Abbott	33	$3,286
Boston Scientific	6	$1,674
Inari Medical, Inc.	6	$792
Philips North America LLC	5	$332
GE HealthCare	2	$294
Shockwave Medical, Inc	1	$265
ZOLL Circulation Inc	1	$191
Procyrion, Inc.	1	$163
W. L. Gore & Associates, Inc.	1	$43

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,742 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Medicare billing

Part B allowed, 2024

$257,470

Medicare patients

395

Services billed

1,087

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	29	$20,683
Amoxicillin	20	$39
Famotidine	11	$26

Paid to pharmacies, not to this prescriber.

Other internal medicine in New York

Stephen SaletanNew York$2.6M
Ziad AliNew York$2M
Ricky HsuNew York$1M
James UnderbergNew York$953K
Terry PlasseNew York$883K
Krisczar BungayNew York$554K
Eytan SteinNew York$496K
Larry NeumanNew York$457K
Wuhua JingNew York$338K
Harvey SchneienNew York$334K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →